Patent Assignment
Reel/Frame 052534/0679
Change of Name
Recorded: 2020-04-30
Pages: 6
Assignor
QR PHARMA, INC.
Executed: 2019-04-09
Assignee
ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300, BERWYN, PENNSYLVANIA, 19312
Covered Properties
(4)
(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Methods of Treatment or Prevention of Acute Brain or Nerve Injuries
(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis via Administration of Posiphen to Healthy or Sick Humans
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 8, 2019
From: MACCECCHINI, MARIA
To: QR PHARMA, INC.
Reel/Frame 049685/0565 →
Assignment of Assignor's Interest
Jul 9, 2019
From: MACCECCHINI, MARIA
To: QR PHARMA, INC.
Reel/Frame 049697/0353 →
Assignment of Assignor's Interest
Mar 24, 2020
From: MACCECCHINI, MARIA
To: QR PHARMA, INC.
Reel/Frame 052210/0159 →